Your search for oral corticosteroids returned 190 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for oral corticosteroids returned 190 results

Sort Results:

Relevant Recent
AAO 2019

Miltefosine May Be Effective for Progressive Acanthamoeba Keratitis

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, conducted by experts in the field. Check back regularly for more news from AAO 2019. SAN FRANCISCO – For patients with progressive Acanthamoeba…
How I Treat

How I Treat: Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is classified as a progressive, inflammatory disease that appears to be primarily caused by inflammation of hair follicles and is most often found in areas of friction of the body, such as the axillae, groin, perineum, and medial thighs. The inflammation associated with HS presents clinically with recurrent inflamed painful nodules and…
Drugs in the Pipeline

Baricitinib Added to Topical Steroids Beneficial in Atopic Dermatitis Trial

Adding baricitinib to topical corticosteroids significantly improved disease severity in adult patients with moderate to severe atopic dermatitis, according to top-line results from BREEZE-AD7 study. The phase 3 study included 300 patients who had been diagnosed with moderate to severe atopic dermatitis for at least 12 months and had an inadequate response to topical medications.…
How I Treat

How I Treat Atopic Dermatitis With Dupilumab

A skin disease of major importance, atopic dermatitis (AD) is characterized by pruritus and a typical morphology and distribution of skin lesions. It is a chronic relapsing inflammatory process often occurring in patients with a personal or family history of other atopic conditions such as bronchial asthma and allergic rhinoconjunctivitis. AD is one of the…
News

Dupilumab Safe, Effective in Pediatric Atopic Dermatitis Trial

Topline results from a phase 3 study investigating dupilumab in the treatment of pediatric patients with severe atopic dermatitis showed that the interleukin-4 receptor alpha antagonist was both safe and effective in this patient population.